Publikationen von Huttner, Michael
(ORCID: 0000-0002-3766-5909)
 | Eine Stufe nach oben |
Anzahl der Einträge: 3.
2024
Simeth, Jakob 
, Hüttl, Paul , Schön, Marian, Nozari, Zahra, Huttner, Michael , Schmidt, Tobias, Altenbuchinger, Michael und Spang, Rainer
(2024)
Virtual Tissue Expression Analysis.
Bioinformatics, btae709.
Huttner, Michael
(2024)
Infrastructure for digital medicine and AI enhanced pathology.
Dissertation, Universität Regensburg.
2019
Staiger, A. M., Altenbuchinger, Michael, Ziepert, M., Kohler, Christian, Horn, H., Huttner, Michael , Huttl, K. S., Glehr, Gunther , Klapper, W., Szczepanowski, M., Richter, J., Stein, H., Feller, A. C., Moller, P., Hansmann, M. L., Poeschel, V., Held, G., Loeffler, M., Schmitz, N., Trumper, L., Pukrop, T., Rosenwald, A., Ott, G., Spang, Rainer , Emed Demonstrator Project, und German High Grade Non-Hodgkin’s Lymphoma Study Group (DSHNHL),
(2019)
A novel lymphoma-associated macrophage interaction signature (LAMIS) provides robust risk prognostication in diffuse large B-cell lymphoma clinical trial cohorts of the DSHNHL.
Leukemia 34, S. 543-552.
Volltext nicht vorhanden.
, Huttl, K. S., Glehr, Gunther , Klapper, W., Szczepanowski, M., Richter, J., Stein, H., Feller, A. C., Moller, P., Hansmann, M. L., Poeschel, V., Held, G., Loeffler, M., Schmitz, N., Trumper, L., Pukrop, T., Rosenwald, A., Ott, G., Spang, Rainer , Emed Demonstrator Project, und German High Grade Non-Hodgkin’s Lymphoma Study Group (DSHNHL),
(2019)
A novel lymphoma-associated macrophage interaction signature (LAMIS) provides robust risk prognostication in diffuse large B-cell lymphoma clinical trial cohorts of the DSHNHL.
Leukemia 34, S. 543-552.
Volltext nicht vorhanden.